Plasma HER2 levels are not associated with cardiac function or hypertrophy in control subjects and heart failure patients

International Journal of Cardiology

Volumn 145, Issue 1, 2010, Pages 105-106

  Posch, Maximilian G ^a   Panek, Anna ^a   Kersten, Andrea ^a   Ghadge, Santhosh Kumar ^a   Geier, Christian ^a   Richter, Silke ^a   Perrot, Andreas ^a   Gailani, Mudather ^a   Dietz, Rainer ^a   Lüftner, Diana ^a   Özcelik, Cemil ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Biomarker; ErbB2; Heart failure; HER2

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGED; DISEASE ASSOCIATION; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE WALL; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE HYPERTROPHY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 78049476152     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.05.056     Document Type: Article

References (16)

1. D.J. Slamon, W. Godolphin, and L.A. Jones Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer Science 244 1989 707 712
2. N.J. Freedman, and G.S. Ginsburg Novel-and "neu"-therapeutic possibilities for heart failure J Am Coll Cardiol 48 2006 1448 1450
3. D.J. Slamon, B. Leyland-Jones, and S. Shak Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 N Engl J Med 344 2001 783 792
4. L.P. Grazette, W. Boecker, and T. Matsui Inhibition of ErbB2 causes mitochondrial dysfunction in cardiomyocytes: implications for herceptin-induced cardiomyopathy J Am Coll Cardiol 44 2004 2231 2238
5. S.A. Crone, Y.Y. Zhao, and L. Fan ErbB2 is essential in the prevention of dilated cardiomyopathy Nat Med 8 2002 459 465
6. A.N. Garratt, C. Ozcelik, and C. Birchmeier ErbB2 pathways in heart and neural diseases Trends Cardiovasc Med 13 2003 80 86
7. C. Ozcelik, B. Erdmann, and B. Pilz Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy Proc Natl Acad Sci U S A 99 2002 8880 8885
8. X. Liu, X. Gu, and Z. Li Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy J Am Coll Cardiol 48 2006 1438 1447
9. I.P. Uray, J.H. Connelly, and V. Thomazy Left ventricular unloading alters receptor tyrosine kinase expression in the failing human heart J Heart Lung Transplant 21 2002 771 782
10. D. Luftner, C. Luke, and K. Possinger Serum HER-2/neu in the management of breast cancer patients Clin Biochem 36 2003 233 240
11. P.J. Perik, E.G. de Vries, and J.A. Gietema Serum HER2 levels are increased in patients with chronic heart failure Eur J Heart Fail 9 2007 173 177
12. D. Luftner, A. Jung, and P. Schmid Upregulation of HER-2/neu by ovarian ablation: results of a randomized trial comparing leuprorelin to CMF as adjuvant therapy in node-positive breast cancer patients Breast Cancer Res Treat 80 2003 245 255
13. K.F. Lee, H. Simon, H. Chen, B. Bates, M.C. Hung, and C. Hauser Requirement for neuregulin receptor erbB2 in neural and cardiac development Nature 378 1995 394 398
14. D. Meyer, and C. Birchmeier Multiple essential functions of neuregulin in development Nature 378 1995 386 390
15. S. Rohrbach, X. Yan, and E.O. Weinberg Neuregulin in cardiac hypertrophy in rats with aortic stenosis. Differential expression of erbB2 and erbB4 receptors Circulation 100 1999 407 412
16. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150